EN
HI
Summary
As of 18 Sep, 2026, Biocon stock price is ₹385. During the trading session, the stock has moved between an intraday low of ₹379.30 and an intraday high of ₹388.00. Over the last 52 weeks, Biocon has traded between ₹337.05 and ₹447.15.
The stock has recorded a trading volume of 79,01,211 shares,. Its Average Traded Price (ATP) is ₹384.57, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 1 @ ₹385.00.
Biocon has an upper circuit limit of ₹418.00 and a lower circuit limit of ₹342.00. The total value traded stands at ₹303.86 CR, and the delivery percentage for the day is 56.88%.
The stock is currently traded with a market lot size of 1. Biocon also offers a dividend yield of 0.13%.
Biocon Share Price Chart
Biocon Share Key Metrics
Volume
79.01 L
Market Cap
62404.95 CR
LTQ@LTP
1@385.00
ATP
384.57
Var Margin
14.57 %
Circuit Range
342-418
Delivery %
56.88 %
Value
303.86 CR
ASM/GSM
No
Market Lot
1
Biocon Fundamentals
P/E Ratio
125.03
P/B Ratio
1.82
Div. Yield
0.13
Sector P/E
40.93
Sector P/B
3.56
Sec. Div. Yield
0.51
Biocon Resistance and Support
Pivot 377.5
Resistance
First Resistance
384.5
Second Resistance
389
Third Resistance
396
Support
First Support
373
Second Support
366
Third Support
361.5
Biocon Futures & Options
Biocon Option Chain
View Price, OI, Greeks & More...
29SEP26
387.55
7.40 (1.95%)
27OCT26
389.10
7.00 (1.83%)
23NOV26
390.20
6.00 (1.56%)
BIOCON|29SEP26 CE 385.00
7.25
3.05 (72.62%)
BIOCON|29SEP26 PE 390.00
6.75
-5.55 (-45.12%)
Biocon Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Fri Sep 18 2026 | 380.05 | 385 | 1.32% | 388 | 379.3 |
| Thu Sep 17 2026 | 374 | 380 | 1.50% | 382 | 370.5 |
| Wed Sep 16 2026 | 381 | 374.39 | -1.99% | 383.5 | 373.5 |
Biocon Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-05 | Quarterly Results |
| 2026-05-07 | Audited Results & Final Dividend |
| 2026-02-12 | Quarterly Results |
| 2025-11-11 | Quarterly Results |
| 2025-10-01 | Redemption (Part) of NCD |
| 2025-08-07 | Quarterly Results |
| 2025-05-08 | Audited Results & Final Dividend |
| 2025-04-23 | Others |
| 2025-04-04 | To consider Fund Raising |
| 2025-01-30 | Quarterly Results & Others |
| 2025-01-27 | Others |
| 2024-10-30 | Quarterly Results |
Biocon News
Biocon Ltd - 532523 - Communication Regarding Remittance Of Final Dividend For The FY 2025-26
Biocon has remitted a final dividend of Rs.0.50 per equity share for the financial year 2025-26 to its eligible shareholders. This dividend was approved at the company's 48th Annual General Meeting held on August 06, 2026, with the record date set as July 03, 2026.
Sep 09 2026 14:02:55
Biocon Ltd - 532523 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Biocon Limited signed a 10-year supply contract for Pertuzumab in Brazil with Bahiafarma and Bionovis. This partnership provides exclusive access to 70% of Brazil's public healthcare market for the HER2-positive breast cancer therapy, ensuring milestone payments and revenue share.
Sep 08 2026 08:31:31
Read More
Biocon Management
| Name | Position |
|---|---|
| Kiran Mazumdar-Shaw | Chairperson |
| Ravi Rasendra Mazumdar | Non Independent & Non Executive Director |
Biocon Similar Stocks
Glenmark Pharmaceuticals Ltd.
2447.40
31.40 (1.30%)
Fortis Healthcare Ltd.
886.00
-0.10 (0.01%)
Aster DM Quality Care Ltd.
755.05
-5.60 (0.74%)
Alkem Laboratories Ltd.
5466.50
118.00 (2.21%)
Abbott India Ltd.
27270.00
1360.00 (5.25%)
Anthem Biosciences Ltd.
928.50
1.10 (0.12%)
Ipca Laboratories Ltd.
2009.60
39.30 (1.99%)
Glaxosmithkline Pharmaceuticals Ltd.
2838.80
38.90 (1.39%)
Gland Pharma Ltd.
2961.90
54.10 (1.86%)
Biocon FAQs
The Buying Price of Biocon share is 385 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Biocon stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Biocon, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Biocon shares is 125.03. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Biocon shares is 1.82. Useful to assess the stock's value relative to its book value.
To assess Biocon’s valuation compare Sector P/E, P/B which are 40.93 & 3.56 with sector averages, along with growth rates and financial metrics.
The Market Cap of Biocon is 62404.95 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Biocon share price is 447.15 & 337.05. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Biocon belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in BIOCON
